Results 151 to 160 of about 33,834 (203)

Antimalarial Mechanisms and Resistance Status of Artemisinin and Its Derivatives. [PDF]

Trop Med Infect Dis
Zheng D, Liu T, Yu S, Liu Z, Wang J, Wang Y.   +5 more
europepmc   +1 more source

Real-world treatment patterns and clinical characteristics in patients with moderate-to-severe systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS). [PDF]

Lupus Sci Med
Aringer M, Arnaud L, Furie RA, Morand EF, Peschken C, Hoi A, Desta B, Hedberg J, Grünfeld Eén T, Sorrentino A, Kielar D, Tummala R, Chen S, Ding B.   +13 more
europepmc   +1 more source

Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study. [PDF]

Ann Rheum Dis
Aranow C, Allaart CF, Amoura Z, Bruce IN, Cagnoli PC, Chatham WW, Clark KL, Furie R, Groark J, Urowitz MB, van Vollenhoven R, Daniels M, Fox NL, Gregan YI, Henderson RB, van Maurik A, Ocran-Appiah JC, Oldham M, Roth DA, Shanahan D, Tak PP, Teng YO.   +21 more
europepmc   +1 more source

Gossypol is a natural product with good antimalarial activity against Plasmodium falciparum clinical isolates. [PDF]

Sci Rep
Chirawurah JD, Ansah F, Blankson S, Adikah B, Yeboah SN, Amenga-Etego L, Awandare GA, Aniweh Y.   +7 more
europepmc   +1 more source

Severity of Vessel Color Changes and Macular and Peripheral Whitening in Malarial Retinopathy Are Associated with Higher Total Body and Sequestered Parasite Burdens. [PDF]

Trop Med Infect Dis
Nwanze C, Muller D, Suleman P, Takle M, Barber JR, Wilson KJ, Beare NAV, Seydel KB, Postels DG.   +8 more
europepmc   +1 more source

Identifying distinct phenotypes of patients with juvenile systemic lupus erythematosus: results from a cluster analysis by the Egyptian college of rheumatology (ECR) study group. [PDF]

BMC Pediatr
Hammam N, Gheita TA, Bakhiet A, Mahmoud MB, Owaidy RE, Nabi HA, Elsaman AM, Khalifa I, ElBaky AMNEA, Ismail F, Hassan E, El Shereef RR, El-Gazzar II, Moshrif A, Khalil NM, Amer MA, Fathy HM, Salam NA, Elazeem MIA, Hammam O, Fathi HM, Tharwat S.   +21 more
europepmc   +1 more source

The Paradigm Shift of Using Natural Molecules Extracted from Northern Canada to Combat Malaria. [PDF]

Infect Dis Rep
Bourgeois A, Lemos JAS, Roucheray S, Sergerie A, Richard D.   +4 more
europepmc   +1 more source

Polymorphisms in Pfkelch13 domains before and after the introduction of artemisinin-based combination therapy in Southwest Nigeria. [PDF]

PLoS One
Amusan A, Akinola O, Akano K, Hernández-Castañeda M, Dick JK, Sowunmi A, Hart G, Gbotosho G.   +7 more
europepmc   +1 more source

Tofacitinib for child-onset systemic lupus erythematosus. [PDF]

Front Immunol
Hou L, Zhou P, Zhao C, Wang X, Du Y.
europepmc   +1 more source

Prompt and Effective Treatment use for Febrile Illness: A Comparison Between two Autonomous Health Administrations in Tanzania [PDF]

Abdulla, S, Ali, AS, Bloland, PB, Elling, BF, Kachur, SP, Khatib, RA, Njau, JD   +6 more
core